News Releases

Einstein's M.D. Class of 2026 Celebrates at Annual White Coat Ceremony
Einstein-Created Drugs Show Promise Against an Incurable Eye Disease
Study Finds That an Autism Deficit May 'Disappear' in Adulthood

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Betsy Herold

Betsy Herold, M.D.

Area(s) of expertise: Infectious diseasesHerpes simplex virusesCOVID-19 and pediatrics

Dr. Herold directs a translational research program focused on the interactions between viruses and their host and using that knowledge to develop novel treatment and prevention strategies. Through her basic science studies, Dr. Herold has developed a unique candidate vaccine… Learn more

Einstein in the News

The New York Times
Pain in Children is Often Ignored. For Children of Color, It's Even Worse

Cristina Gonzalez, M.D., M.Ed., an expert in implicit bias recognition and management, recalls the case of a young Hispanic patient whose caregivers initially doubted his pain level, which could have delayed his treatment and led to life-threatening damage. Dr. Gonzalez is professor of medicine at Einstein and a hospitalist at Montefiore.

Monocolonal Antibody Might Help Prevent Malaria

Johanna Daily, M.D., M.S., comments on a study that found a lab-engineered antibody effective in protecting most participants from malaria infection. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.

Additional coverage includes UPI, MedPage Today

More coverage on Dr. Daily

NBC News
World's First HIV-Positive to HIV-Positive Heart Transplant Performed at NYC Hospital

Ulrich Jorde, M.D., says the first HIV-positive to HIV positive heart transplant, performed at Montefiore, is a milestone in the history of organ donation. Dr. Jorde is professor of medicine at Einstein and head of heart failure, cardiac transplantation & mechanical circulatory support and vice chief of the division of cardiology at Montefiore.


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog